Inventor · disambiguated record
K. Gary J. Vanasse
Also filed as: VANASSE K GARY J
0 granted patents·9 pending applications·0 citations·filing 2014–2022
Top patents by PatentIndex Score
9 records- 0156US2023088070A1Use of il-1beta binding antibodiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0252US2019290627A1Pim kinase inhibitor combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0351US2024301054A1Tim-3 inhibitors and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0450US2022332821A1Dosing regimen and combination therapies for multispecific antibodies targeting b-cell maturation antigenNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0549US2016175293A1Pim kinase inhibitor combinationsCAO ZHU ALEXANDER·Filed 2014·Application pending·0 cites
- 0649US2023057071A1Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndromeNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0748US2020369762A1Use of il-1beta binding antibodiesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0848US2017368044A1Pim kinase inhibitor combinationsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 0947US2021213063A1Combination therapy with chimeric antigen receptor (car) therapiesNOVARTIS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when K. Gary J. Vanasse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →